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O B J E C T I V E S This study sought to evaluate the prevalence of subclinical myocardial infarctions
with cardiovascular magnetic resonance imaging (CMRI) in patients with patent foramen ovale (PFO)
after cryptogenic cerebral ischemic events.
B A C KG ROUND A thrombotic mass passing a PFO may embolize in cerebral but also in coronary
arteries, resulting in both cerebral and myocardial ischemic events. CMRI with late gadolinium
enhancement (LGE) analysis is the most sensitive imaging technique to detect small myocardial
infarctions.
METHOD S PFO patients (n  74) with a ﬁrst cryptogenic cerebral ischemic event without a clinical
history for myocardial infarction underwent CMRI and coronary angiography. Right and left ventricular
volumes and ejection fractions were measured by CMRI. LGE imaging was performed after administra-
tion of gadolinium-diethylenetriaminepentaacetic acid. The presence of atrial septal aneurysm (ASA) was
evaluated by transesophageal echocardiography.
R E S U L T S LGE was detected in 8 of 74 (10.8%) patients. LGE pattern was transmural or subendo-
cardial. Patients with LGE and those without did not differ in cardiovascular risk factors, type of ischemic
event, presence of ASA, right and left ventricular volumes, and ejection fractions. LGE volume was small
and comprised only 7.9  2.4% of left ventricular muscle mass. Coronary artery disease was ruled out
in 7 of 8 patients with LGE. There was a trend towards a larger PFO size in patients with LGE compared
with patients without LGE (13.2  4.1 mm vs. 16.0  2.8 mm, p  0.06).
CONC L U S I O N S Subclinical myocardial infarctions determined in CMRI were observed in 10.8% of
patients with PFO after a ﬁrst cryptogenic cerebral ischemic event. Our results strengthen the
pathophysiologic role of a PFO with paradoxical embolism in patients with cryptogenic cerebral
ischemic events. (J Am Coll Cardiol Img 2010;3:833–9) © 2010 by the American College of Cardiology
Foundation
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834here is an increasing use of percutaneous
transcatheter device implantation for closure
of patent foramen ovale (PFO) after crypto-
genic ischemic events (1) although the patho-
hysiologic role of the PFO is controversial (2,3).
ccording to the American Heart Association/
merican Stroke Association PFO closure may be
onsidered for patients with recurrent cryptogenic
troke despite optimal medical therapy (4), not
aking into account other noncerebral embolic
vents. Cerebral vessels are the main target of
ardiac emboli. Nevertheless, other vessels such as
See page 840
oronary arteries may also be affected. The evidence
f a thrombus in a PFO has been documented (5,6).
n these rare cases, the thrombotic mass was ex-
raordinary large. In the vast majority, there is no
hrombus in a PFO of a patient with a cryptogenic
cerebral ischemic event despite use of
transesophageal echocardiography. The
absence of a thrombus in PFO patients
with cryptogenic ischemic events has often
been used as an argument against the
pathophysiologic role of a PFO with para-
doxical embolism. However, a small throm-
botic mass could easily pass the PFO with-
out entrapment, leading to cerebral ischemic
events. Entering the coronary arteries, the
resulting small myocardial infarction (MI)
could be subclinical or even asymptomatic.
Cardiovascular magnetic resonance imaging
(CMRI) with late gadolinium enhancement
LGE) analysis is the most sensitive noninvasive
maging technique to detect even small MIs (7). The
dditional presence of a subclinical MI in the absence
f coronary artery disease supports the hypothesis of
aradoxical embolus as the underlying mechanism of
ryptogenic stroke. The confirmation that a single
atient has had 2 potential paradoxical embolic events,
he combination of MI and stroke, would also support
ercutaneous closure of PFO by device implantation.
We evaluated the prevalence of MI with CMRI
n patients after a first cryptogenic ischemic cerebral
vent and presence of a PFO.
E T H O D S
eventy-four consecutive patients with a first cryp-
ogenic ischemic cerebral event and PFO seen in
etic
ticransesophageal echocardiography without clinical ristory of MI were included. Patients underwent
MRI study including LGE imaging for detection
f MI. The cerebral ischemic event was classified as
ryptogenic if other possible causes were excluded
uch as atherosclerotic stenoses or plaques of the
arotid or vertebral arteries, aortal plaques, cardiac
rrhythmias including atrial fibrillation or flutter,
rothrombotic coagulation disorders, or cardiac
hrombi. All patients underwent a diagnostic
orkup with 12-lead electrocardiography, Holter
onitoring, Doppler sonography, transthoracic
chocardiography, transesophageal echocardiogra-
hy, and coagulation blood tests. Transesophageal
chocardiography and CMRI were used to rule out
ntracardiac thrombi in both the atrial and ventric-
lar chambers. Patients were scheduled for percu-
aneous closure of PFO based on the cryptogenic
erebral ischemic event in combination with the
resence of an atrial septal aneurysm (ASA) or
evere bubble passage seen in transesophageal echo-
ardiography. All patients were in sinus rhythm,
nd there was no indication for oral anticoagulation
ue to other disorders. The study was approved by
he local ethics committee, and all patients gave
heir written informed consent.
ransesophageal echocardiography. Transesopha-
eal echocardiography for detection of PFO was
erformed with a multiplane, phased-array 4- to
-MHz transesophageal echocardiography probe
n an ATL HDI 5000 CV (Philips Medical Sys-
ems, Best, the Netherlands). For contrast enhance-
ent, 10 ml of agitated hydroxyethyl starch solu-
ion was repeatedly administered into an antecubital
ein with the patient performing proper Valsalva
aneuver (8). Provokable right-to-left shunt was
raded according to the amount of bubbles crossing
he interatrial septum: no shunt 0, mild shunt1
o 9 bubbles, moderate shunt  10 to 20 bubbles,
nd severe shunt 20 bubbles or opacified left
trium due to bright contrast (9). The contrast
gent was administrated through a cubital vein. An
SA was defined as an excursion of the atrial
eptum 10 mm (10).
MRI. CMRI was performed on a 1.5-T Intera CV
hole-body MR Scanner (Philips Medical Sys-
ems). All data were acquired utilizing a dedicated
-element cardiac phased-array coil. To determine
eft and right ventricular function, a retrospective
CG-gated segmented k-space balanced turbo
eld-echo sequence (steady-state free-precession
SSFP]) was used in short- and long-axis views
long the true heart axis (11). Depending on theB B R E V I A T I O N S
N D A C R O N YM S
SA atrial septal aneurysm
MRI cardiovascular magn
esonance imaging
d-DTPA gadolinium-
iethylenetriaminepentaace
cid
GE late gadolinium
nhancement
Imyocardial infarctionequired field of view, the spatial resolution was
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835etween 1.7 1.8 mm and 2.3 1.8 mm in-plane.
lice thickness was 10 mm. Echo time was 1.7 ms.
epetition time was 3.4 ms. Ten to 15 min after
nfusion of 0.2 mmol/kg body weight gadolinium-
iethylenetriaminepentaacetic acid (Gd-DTPA,
agnevist, Schering, Germany), a LGE study using a
D spoiled turbo gradient-echo sequence with a se-
ective 180° inversion recovery pre-pulse was acquired
n the short axis covering the whole left ventricle (20-
o 22 5-mm slices). Two to 3 long-axis views with a
imilar 2D sequence were additionally performed.
GE was quantitatively assessed on a ViewForum
orkstation with the Easy Vision Software Rel. 5.1
Philips Medical Systems) (12).
oronary angiography. Coronary angiography was
erformed in standard Judkins technique from the
emoral approach using 5-F or 6-F catheters. For
he right coronary artery, 2 to 3 projections and for
he left coronary artery, 5 to 7 projections were
erformed after intracoronary administration of
lycerol trinitrate. Exclusion of coronary artery
isease was defined as a smooth vessel border
ithout luminal stenoses or irregularities.
tatistical analysis. Categorical parameters are pre-
ented as counts and percentages. Comparison of
roportions was done with chi-square test. Normal
istribution for continuous variables were tested by
se of the Kolmogorov-Smirnov test, and data are
resented as mean  SD. Continuous variables for
groups were compared using the unpaired t test. A
value 0.05 was considered significant. Analyses
ere done with Statistica release 7.1 (StatSoft,
ulsa, Oklahoma).
E S U L T S
GE in CMRI was present in 8 of 74 (10.8%)
atients. Patients with LGE as compared with
atients without LGE did not differ in cardiovas-
ular risk profile or type of cryptogenic cerebral
schemic event (Table 1). An ASA was present in
4% of the population, and its presence did not
iffer between patients with LGE and patients
ithout LGE.
Severe bubble passage was present in 61 of 74
atients (82.4%) and was not different between
roups. Severe bubble passage was seen in 7 of 8
87.5%) patients with LGE in CMRI as compared
ith 54 of 66 (81.8%) patients without LGE (p 
.69). PFO size in patients with severe bubble
assage was statistically not different from patients
ithout severe bubble passage (13.9  4.1 mm vs.
1.8  3.1 mm, p  0.11). Patients with ASA had asignificantly larger PFO size (14.4  3.9 mm) as
ompared with patients without ASA (12.0  3.8
m, p 0.012). There was a trend towards a larger
ize of PFO in patients with LGE as compared to
atients without LGE (16.0  2.8 mm vs. 13.2 
.1 mm, p  0.06) (Table 1).
Signs of MI in 12-lead electrocardiography were
resent in 3 of 8 (37.5%) patients with LGE as
etailed in Figure 1. In these 3 patients, the
istribution of LGE was appropriate for the distri-
ution of electrocardiogram’s indication of MI.
ith coronary angiography, coronary artery disease
as ruled in 7 of 8 (87.5%) patients with LGE.
alues for LV and RV volume indices and ejection
ractions were in normal range and did not differ
etween patients with or without LGE (Table 2).
attern of LGE in CMRI was transmural or
ubendocardial (Fig. 2). LGE comprised 7.9 
.4% (median 6.0%, range 2.4% to 17.7%) of left
entricular muscle mass.
I S C U S S I O N
n nonrandomized comparisons, the recurrence rate
f stroke after transcatheter closure of PFO was
ower compared with trials that used medical treat-
ent (13). Nevertheless, with the lack of random-
zed data, the pathophysiologic role of PFO in
ryptogenic stroke patients is controversially de-
ated (2,3). We were able to demonstrate that LGE
maging using CMRI in those patients detects
ubclinical MI in about every tenth patient. The
Table 1. Patient Characteristics
Total Population Without LGE
Patients 74 66
Mean age (yrs) 45.9 13.4 45.2 13.0
Male, n 45 (60.8%) 40 (60.6%)
Index event
Stroke 60 (81.1%) 53 (80.3%)
Transient ischemic attack 14 (18.9%) 13 (19.7%)
Cardiovascular risk factors
Diabetes 3 (4.1%) 3 (4.5%)
Hypertension 25 (33.8%) 22 (33.3%)
Active smoker 16 (21.6%) 15 (22.7%)
Hyperlipidemia 23 (31.1%) 21 (31.8%)
Body mass index (kg/m2) 25.8 3.9 25.9 4.0
PFO size, mm 13.4 4.0 13.2 4.1
Atrial septal aneurysm 47 (63.5%) 42 (63.6%)
Coronary artery disease 5 (6.8%) 4 (6.1%)
Values are n, mean  SD, or n (%).
LGE  late gadolinium enhancement; PFO  patent foramen ovale.With LGE p Value
8
51.8 16.2 0.17
5 (62.5%) 0.92
7 (87.5%)
0.62
1 (12.5%)
0 (0.0%) 0.54
3 (37.5%) 0.82
1 (12.5%) 0.62
2 (25.0%) 0.69
25.2 2.7 0.84
16.0 2.8 0.06
5 (62.5%) 0.95
1 (12.5%) 0.49dditional presence of a subclinical MI in the
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836bsence of coronary artery disease supports the
ypothesis of paradoxical embolus as the underlying
echanism of cryptogenic stroke.
MI as a consequence of paradoxical embolism via
PFO has been reported in some cases (14). In our
opulation, MIs were predominantly small and did
ot affect LV volumes or ejection fraction, which
ere in normal range. The median LGE was 6.0%
f left ventricular muscle mass. Amount of LGE
as very limited compared with values for MIs due
o coronary artery disease (12,15–18). The mainly
mall size of LGE also strengthens the hypothesis
f paradoxical embolism of thrombotic material. A
12-Lead Electrocardiography With 50 mm/s for Patients With LGE
yocardial infarction were seen in 3 patients (inferior in A and F; apica
gadolinium enhancement.
ar Magnetic Resonance Imaging
Total Population Without LGE With LGE p Value
ters
71.2 13.5 71.1 13.5 72.6 13.9 0.76
23.4 7.6 23.0 7.2 26.5 10.1 0.22
62.3 10.1 61.9 10.6 64.9 5.3 0.44
67.7 6.3 68.1 5.7 64.4 9.7 0.12
eters
79.2 18.3 79.7 18.4 74.5 18.2 0.47
29.0 9.9 29.3 10.1 26.5 8.2 0.46
64.0 5.6 63.9 5.7 64.9 4.6 0.63
ter
m2) 3.1 0.5 3.1 0.5 3.4 0.5 0.21
SD.
EDVI  end-diastolic volume index; EF  ejection fraction; ESVI  end-systoliclntricular; MMI  muscle mass index; RV  right ventricular.mall thrombotic mass can result in subclinical MI
ithout evidence of thrombus in PFO even by use
f transesophageal echocardiography.
The presence of LGE is not pathognomonic for
I. LGE has also been documented in different
ypes of cardiomyopathy (19), myocarditis (19,20),
nd Takotsubo disease (21). In our population,
GE was transmural or subendocardial, which is
he typical presentation of myocardial scar due to
I (20). In addition, coronary artery disease was
uled out in 7 of 8 patients by coronary angiogra-
hy. Therefore, we interpret the presence of LGE
s MI.
Multiple cerebral ischemic lesions on diffusion-
eighted magnetic resonance imaging have been
orrelated to the presence of PFO seen in trans-
sophageal echocardiography (22). In 106 patients
ith cryptogenic stroke, no difference was observed
etween patients with PFO as compared with
atients without PFO. The frequency of multiple
schemic lesions on magnetic resonance imaging in
elation to right-to-left shunting has been recently
tudied by Feurer et al. (23). Multiple ischemic
esions were seen in 23 of 165 (13.9%) patients with
ight-to-left shunt in comparison with 45 of 321
atients (14.0%) without right-to-left shunt (p 
.98). In the subgroup of patients with cryptogenic
troke, there was a 3-fold higher frequency of
ultiple ischemic lesions in patients with right-to-
CMRI
H). CMRI  cardiac magnetic resonance imaging;Figure 1. in
Signs of m l inTable 2. Cardiovascul
Left ventricular parame
LVEDVI (ml/m2 BSA)
LVESVI (ml/m2 BSA)
LVMMI (g/m2 BSA)
LVEF (%)
Right ventricular param
RVEDVI (ml/m2 BSA)
RVESVI (ml/m2 BSA)
RVEF (%)
Hemodynamic parame
Cardiac index (l/min/
Measurements are mean 
BSA  body surface area;eft shunt (4 of 65, 6.2%) as compared with patients
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837ithout right-to-left shunt (2 of 86, 2.3%). The
mpact of an ASA in the context of multiple
erebral lesions has been evaluated by Bonati et al.
24). Multiple ischemic lesions in diffusion-
eighted CMRI were significantly more frequent
n cryptogenic stroke patients with PFO and ASA
16 of 30, 53%) versus patients with PFO without
SA (3 of 18, 17%; p  0.01). This association
emained significant after correction for PFO size,
egree of right-to-left shunting, and vascular risk
actors. In our study population, an ASA was
resent in 64% of patients. The presence of an ASA
as not associated with a higher frequency of LGE
n CMRI, but was associated with a strong trend
owards a larger PFO size. This association was
ignificant in the study by Bonati et al. (24). The
resence of ASA has also been associated with a
orse long-term prognosis with antiplatelet therapy
25), but not after percutaneous device implantation
26). Our population is pre-selected by the high
requency of ASA (64%), which has been reported
or stroke patients in the range of 2% to 15%
27,28). The frequency of LGE in an unselected
roup of patients with cryptogenic ischemic cerebral
vents could be different from our presented results.
Recently, a lower atherosclerotic burden mea-
ured by carotid intima-media thickness was re-
orted in patients with a cryptogenic cerebral isch-
mic event and PFO compared with patients
ithout PFO (29). The authors concluded that a
onatherosclerotic mechanism may mediate the
erebrovascular event in the presence of PFO. We
Figure 2. The Presence of LGE in CMRI
Panels correspond to those in Figure 1. The predominant circumscr
restricted to the supplying area of 1 coronary artery. LGE was locat
anterolateral in G. Abbreviations as in Figure 1.ere able to extend this knowledge that in those aatients, MIs are detectable in about 10%. Crump
t al. (30) did not find a difference in presence of
FO in 18 patients with MI and normal coronary
ngiograms as compared with 18 patients matched
y age and sex. PFO prevalence was 28% in both
roups and was presumably underdetected since
ontrast medium was injected immediately before
xhalation, which does not meet the requirements
f a proper Valsalva maneuver (8). Although use of
ransthoracic echocardiography allows an easier
alsalva maneuver, a full contrast of the right
trium in conjunction with a higher pressure nec-
ssary for opening a PFO is often missed due to the
espiratory shift of the echocardiographic window.
On the basis of our data, we were not able to
ifferentiate between a 1-step and a 2-step event.
he trend for a larger PFO size in patients with
yocardial scar may be a marker for a second event
llowing a simpler passage of paradoxical emboli or
therwise a passage of a larger clot with following
ragmentation. The fact that a single patient has
ad 2 potential paradoxical embolic events, the
ombination of MI and stroke, also supports per-
utaneous closure of PFO by device implantation.
tudy limitations. There was no control group of
ryptogenic stroke patients without PFO, and the
umber of patients studied was limited. We did not
onsider left atrial appendage flow velocity as a
urrogate for potential left atrial appendage throm-
us. However, left atrial appendage thrombus was
xcluded by transesophageal echocardiography.
urthermore, the population was pre-selected with
myocardial scars were subendocardial or transmural, and
ferior in A, C, and F; apical in B, E, and H; inferolateral in D; andibed
ed inhigh frequency of ASA or presence of severe
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838ubble passage via PFO. Therefore, the 10.8% inci-
ence of LGE in CMRI does not apply to a nonse-
ected population with a first cryptogenic cerebral
schemic event. Nevertheless, the data strongly sup-
ort a paradoxical embolism in the studied population
n which a medical treatment strategy is favored
ccording to present guidelines (4).
O N C L U S I O N S
e were able to demonstrate using CMRI a 10.8%diol 2005;45:1145–6. clear bone marrowfter a first cryptogenic cerebral ischemic event. Our
esults strengthen the pathophysiologic role of a PFO
ith paradoxical embolism in patients with crypto-
enic cerebral ischemic events.
eprint requests and correspondence: Prof. Dr. Jochen
öhrle, Clinic of Internal Medicine II, University of
lm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
prevalence of subclinical MIs in patients with PFO E-mail: jochen.woehrle@uniklinik-ulm.de.1
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